Fenofibrate 145mg Tablets

Fenofibrate 145mg tablet is a fibrate used with diet and other metabolic measures to lower high triglycerides and treat selected mixed lipid disorders. It is not a substitute for statin treatment when LDL reduction or cardiovascular-risk management requires a statin.
Take the tablet with a meal at a consistent daily time. Continue the lipid-focused diet and keep liver, kidney and lipid tests. Report new muscle pain, weakness or dark urine, especially if a statin is also being taken.
Fenofibrate activates PPAR-alpha, increasing lipoprotein lipase activity and triglyceride-rich particle clearance while reducing VLDL production.
Abdominal pain, nausea, headache, digestive upset and raised liver enzymes can occur. Unexplained muscle weakness, dark urine, jaundice or severe abdominal pain requires prompt assessment.
Tell your doctor about kidney, liver or gallbladder disease, pancreatitis, an underactive thyroid or diabetes. Mention pregnancy, breastfeeding, alcohol, statins, colchicine, warfarin and other cholesterol-lowering medicines.
Lowers triglycerides and can improve mixed lipid abnormalities. A fall in triglycerides does not by itself establish that pancreatitis or cardiovascular events have been prevented.
Fenofibrate has a particular role when triglycerides are substantially raised. Statins have a different principal role in LDL reduction and cardiovascular-risk management, so the medicines are not direct substitutes.
No. Fenofibrate formulations differ in particle size and absorption. Similar-looking strengths do not establish equivalent exposure or identical food requirements.
The combination is used in selected circumstances, but increases the importance of watching for muscle injury. Kidney impairment and an underactive thyroid can add to this risk.
High triglycerides often cause no symptoms. Follow-up lipid blood tests show the response more reliably than changes in how you feel.
Fenofibrate can raise serum creatinine, and reduced kidney function changes how the medicine is handled. The results help determine whether the current formulation and treatment remain suitable.
Triglycerides: fats carried in the bloodstream; Mixed dyslipidaemia: an abnormal pattern involving more than one blood lipid; PPAR-alpha: a receptor that regulates lipid metabolism; Creatinine: a blood marker used when assessing kidney function; AR: Fenofibrate 145mg أقراص; FR: Fenofibrate 145mg comprimés; PT: Fenofibrate 145mg comprimidos; ES: Fenofibrate 145mg comprimidos; RU: Fenofibrate 145mg таблетки; ID: Fenofibrate 145mg tablet; VI: Fenofibrate 145mg viên nén; MS: Fenofibrate 145mg tablet; TL: Fenofibrate 145mg tableta; ZH-SG: Fenofibrate 145mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Fenofibrate 145mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Fenofibrate 145mg Tablets